Novozymes A/S
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NVZMF | SQM | JUBLINGREA.BO | BCPC | FF | BGLC | |
|---|---|---|---|---|---|---|
| Market cap | 32.53B | 16.84B | 93.57B | 5.30B | 254.41M | 3.12M |
| P/E (TTM) | 44.6 | 12.1 | 29.3 | 31.4 | — | — |
| Forward P/E | 38.1 | 8.5 | 20.6 | 26.5 | 7.3 | — |
| Price/book | 2.6 | 2.7 | 2.8 | 4.0 | 1.7 | 0.3 |
| Dividend yield | 1.46% | 4.02% | 0.83% | 0.57% | 0.69% | — |
| 1-year change | +17.17% | +30.89% | −8.64% | +9.77% | +48.35% | −77.93% |
| Today | +1.18% | −2.26% | −5.89% | −1.42% | −0.51% | −5.53% |
The closest companies by business and industry (Specialty Chemicals). Prices may be delayed up to 15 min.
Latest news
All NVZMF news ›Novozymes A/S (OTCMKTS:NVZMF) Share Price Crosses Above Fifty Day Moving Average – What’s Next?
Posted by Defense World Staff on Oct 17th, 2026 Novozymes A/S (OTCMKTS:NVZMF – Get Free Report)’s share price passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $66.76 and traded…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com5
- defenseworld.net1
- marketscreener.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.